Latest Conceptus (CPTS) Headlines
Kathryn Tunstall Appointed To STAAR Surgical Board Of Directors
PR Newswire - Thu Jan 30, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the appointment of Kathryn Tunstall to its Board of Directors. Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a developer, maker, and marketer of medical devices for women. In 2013 Conceptus was acquired by Bayer AG for $1.1 billion. Her appointment expands the number of directors to seven.
Global Gynecological Devices Market Report 2012 - 2018
M2 - Thu Oct 31, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mcnjfc/gynecological) has announced the addition of the "Global Gynecological Devices Market Report 2012 - 2018" report to their offering. The global gynecological devices market holds prime importance in the overall medical devices market due to increase in specialized gynecological procedures and rising gynecological conditions with increasing awareness being the major factors driving the growth of this market. The market for these devices is classified into four major segments and is estimated in terms of USD million, for the period 2012 - 2018, keeping 2011 as the base year. The report on the global gynecological devices market includes aspects of gynecologic surgical devices, diagnostic imaging systems, gynecological chairs, and the hand instruments market. The report covers the performance of various segments of the gynecological devices market in terms of revenues generated in such segments. The overall gynecological devices market is classified on the basis of the types of products used in gynecological examinations and operative settings. The report provides an in-depth analysis of the sub-segments of the gynecological devices market with estimated forecast of the market size from 2012 to 2018. The base year for this forecast is 2011 and the compounded annual growth rate is calculated from 2012 to 2018. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Dynamics 3.3 Porter's Five Forces Analysis for Gynecological Devices Market 3.4 Market Attractiveness Analysis of Global Gynecological Devices Market, 2011 3.5 Market Share Analysis of Global Gynecological Devices Market 4 Global Gynecology Devices Market, by Product Types 4.1 Introduction 4.2 Surgical Devices 4.3 Hand Instruments 4.4 Diagnostic Imaging Systems (Ultrasound) 5 Global Gynecological Devices Market, By Geography 6 Recommendations 6.1 Market Strategy for Success 6.2 Barriers to be Considered 7 Company Profiles Companies Mentioned - Boston Scientific Corporation - Conceptus, Inc. - Coopersurgical, Inc. - Ethicon, Inc. - Hologic, Inc. - Karl Storz Gmbh & Co. Kg - Medtronic, Inc. - Olympus Corporation - Richard Wolf Gmbh - Stryker Corporation - Welch Allyn For more information visit http://www.researchandmarkets.com/research/mc...ecological
Accuray says Lichtwardt replaces Bertocci as CFO
AP - Tue Sep 03, 2:10PM CDT
SUNNYVALE, Calif. (AP) — Radiation-treatment equipment maker Accuray Inc. said Chief Financial Officer Derek Bertocci has resigned, effective Monday.
Accuray Incorporated CFO Resigns
PR Newswire - Tue Sep 03, 7:30AM CDT
Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013. Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately. Mr. Bertocci is anticipated to continue in a consulting role with the Company.
Mark Sieczkarek Elected Chairman of the Board of Solta Medical
PR Newswire - Wed Jun 12, 5:30AM CDT
Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that its Board of Directors has elected Mark M. Sieczkarek as its Chairman. Mr. Sieczkarek has been a member of the Board of Directors since July 2006 and has served as lead director since January 2008. He has more than 18 years of leadership experience in the medical device industry and served as President and CEO of Conceptus, Inc. from 2003 to 2011. Mr. Sieczkarek succeeds Stephen J. Fanning, who remains as President and Chief Executive Officer of Solta Medical.
BIOLASE Holds Annual Meeting of Shareholders
Marketwire - Fri Jun 07, 7:30AM CDT
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, announced today that it held its Annual Meeting of Stockholders on Thursday, June 6, at the Company's corporate headquarters in Irvine, CA, as scheduled. A quorum representing approximately 80 percent of stockholders was present in person or by proxy, and all proposals submitted were approved.
MDT Cease IN.PACT Admiral Enrollment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 06, 6:10PM CDT
Medtronic has enrolled a significant number of patients for the IN.PACT Admiral drug-eluting balloon studies.
CYBX Earnings Beat; Expects Strong FY14 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 06, 1:10PM CDT
Cyberonics' fourth-quarter and fiscal 2013 results beat the Zacks Consensus Estimate.
MDT's Catheter Gets Regulatory Approvals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 05, 10:18PM CDT
Medtronic recently received clearance from both the US Food and Drug Administration and the European CE Mark for its Pacific Plus percutaneous transluminal angioplasty (PTA) catheter.
ZMH Acquires NORMED - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 05, 7:00PM CDT
Zimmer Holdings recently announced the acquisition of NORMED Medizin-Technik GmbH, a Germany-based medical company.
Tender offer successful: -- Bayer acquires majority interest in Conceptus -- 96.4 percent of Conceptus' shares tendered / Conceptus imminently to become a wholly-owned Bayer subsidiary
M2 - Wed Jun 05, 9:32AM CDT
The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ:CPTS). As of the expiration of the offer period last night, 31,983,536 shares were validly tendered and not withdrawn in the tender offer, representing approximately 96.4 percent of the currently outstanding shares -- including 2,198,177 shares delivered through notices of guaranteed delivery, representing approximately 6.6 percent of the currently outstanding shares. Bayer has accepted for payment all shares validly tendered into and not withdrawn from the tender offer and will promptly make payment for such shares.
Bayer completes offer for Conceptus shares
By The Associated Press - AP - Wed Jun 05, 5:58AM CDT
German drug company Bayer AG has acquired a majority stake in birth control maker Conceptus Inc. and expects its $1.1 billion purchase of the California company to be completed soon.
Tender offer successful: Bayer acquires majority interest in Conceptus
PR Newswire - Wed Jun 05, 1:30AM CDT
The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ: CPTS). As of the expiration of the offer period last night, 31,983,536 shares were validly tendered and not withdrawn in the tender offer, representing approximately 96.4 percent of the currently outstanding shares - including 2,198,177 shares delivered through notices of guaranteed delivery, representing approximately 6.6 percent of the currently outstanding shares. Bayer has accepted for payment all shares validly tendered into and not withdrawn from the tender offer and will promptly make payment for such shares.
COV Begins Nellcor Labeling Process - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 31, 10:45PM CDT
Covidien has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for CCHD screening in infants.
Medtronic Endovascular Biz in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 31, 6:20PM CDT
Medtronic gain FDA approval for two products under its endovascular aortic repair portfolio.
The Zacks Analyst Blog Highlights: Roche Holding, Bayer, Conceptus, Teva Pharmaceutical Industries and Jazz Pharmaceuticals Public
PR Newswire - Fri May 31, 9:01AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Roche Holding AG (OTC:RHHBY), Bayer (OTC:BAYRY), Conceptus Inc. (Nasdaq:CPTS), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Jazz Pharmaceuticals Public Ltd (Nasdaq:JAZZ).
Bayer a Step Closer to Conceptus Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 30, 8:40PM CDT
Bayer received antitrust clearance from the FTC with respect to the acquisition of Conceptus.
COV Progresses Further with Spin-Off - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 30, 1:40PM CDT
Covidien's board of directors has given a green signal for the divestment, to be effective by end-June with the declaration of a dividend.
Good News for HOLX after Weak 2Q13 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 29, 6:40PM CDT
Hologic wins FDA approval for its C-View 2D imaging software.
Kathryn Tunstall Appointed To STAAR Surgical Board Of Directors
PR Newswire - Thu Jan 30, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the appointment of Kathryn Tunstall to its Board of Directors. Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a developer, maker, and marketer of medical devices for women. In 2013 Conceptus was acquired by Bayer AG for $1.1 billion. Her appointment expands the number of directors to seven.
Global Gynecological Devices Market Report 2012 - 2018
M2 - Thu Oct 31, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mcnjfc/gynecological) has announced the addition of the "Global Gynecological Devices Market Report 2012 - 2018" report to their offering. The global gynecological devices market holds prime importance in the overall medical devices market due to increase in specialized gynecological procedures and rising gynecological conditions with increasing awareness being the major factors driving the growth of this market. The market for these devices is classified into four major segments and is estimated in terms of USD million, for the period 2012 - 2018, keeping 2011 as the base year. The report on the global gynecological devices market includes aspects of gynecologic surgical devices, diagnostic imaging systems, gynecological chairs, and the hand instruments market. The report covers the performance of various segments of the gynecological devices market in terms of revenues generated in such segments. The overall gynecological devices market is classified on the basis of the types of products used in gynecological examinations and operative settings. The report provides an in-depth analysis of the sub-segments of the gynecological devices market with estimated forecast of the market size from 2012 to 2018. The base year for this forecast is 2011 and the compounded annual growth rate is calculated from 2012 to 2018. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Dynamics 3.3 Porter's Five Forces Analysis for Gynecological Devices Market 3.4 Market Attractiveness Analysis of Global Gynecological Devices Market, 2011 3.5 Market Share Analysis of Global Gynecological Devices Market 4 Global Gynecology Devices Market, by Product Types 4.1 Introduction 4.2 Surgical Devices 4.3 Hand Instruments 4.4 Diagnostic Imaging Systems (Ultrasound) 5 Global Gynecological Devices Market, By Geography 6 Recommendations 6.1 Market Strategy for Success 6.2 Barriers to be Considered 7 Company Profiles Companies Mentioned - Boston Scientific Corporation - Conceptus, Inc. - Coopersurgical, Inc. - Ethicon, Inc. - Hologic, Inc. - Karl Storz Gmbh & Co. Kg - Medtronic, Inc. - Olympus Corporation - Richard Wolf Gmbh - Stryker Corporation - Welch Allyn For more information visit http://www.researchandmarkets.com/research/mc...ecological
Accuray says Lichtwardt replaces Bertocci as CFO
AP - Tue Sep 03, 2:10PM CDT
SUNNYVALE, Calif. (AP) — Radiation-treatment equipment maker Accuray Inc. said Chief Financial Officer Derek Bertocci has resigned, effective Monday.
Accuray Incorporated CFO Resigns
PR Newswire - Tue Sep 03, 7:30AM CDT
Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013. Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately. Mr. Bertocci is anticipated to continue in a consulting role with the Company.
Mark Sieczkarek Elected Chairman of the Board of Solta Medical
PR Newswire - Wed Jun 12, 5:30AM CDT
Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that its Board of Directors has elected Mark M. Sieczkarek as its Chairman. Mr. Sieczkarek has been a member of the Board of Directors since July 2006 and has served as lead director since January 2008. He has more than 18 years of leadership experience in the medical device industry and served as President and CEO of Conceptus, Inc. from 2003 to 2011. Mr. Sieczkarek succeeds Stephen J. Fanning, who remains as President and Chief Executive Officer of Solta Medical.
BIOLASE Holds Annual Meeting of Shareholders
Marketwire - Fri Jun 07, 7:30AM CDT
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, announced today that it held its Annual Meeting of Stockholders on Thursday, June 6, at the Company's corporate headquarters in Irvine, CA, as scheduled. A quorum representing approximately 80 percent of stockholders was present in person or by proxy, and all proposals submitted were approved.
MDT Cease IN.PACT Admiral Enrollment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 06, 6:10PM CDT
Medtronic has enrolled a significant number of patients for the IN.PACT Admiral drug-eluting balloon studies.
CYBX Earnings Beat; Expects Strong FY14 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 06, 1:10PM CDT
Cyberonics' fourth-quarter and fiscal 2013 results beat the Zacks Consensus Estimate.
MDT's Catheter Gets Regulatory Approvals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 05, 10:18PM CDT
Medtronic recently received clearance from both the US Food and Drug Administration and the European CE Mark for its Pacific Plus percutaneous transluminal angioplasty (PTA) catheter.
ZMH Acquires NORMED - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 05, 7:00PM CDT
Zimmer Holdings recently announced the acquisition of NORMED Medizin-Technik GmbH, a Germany-based medical company.
Tender offer successful: -- Bayer acquires majority interest in Conceptus -- 96.4 percent of Conceptus' shares tendered / Conceptus imminently to become a wholly-owned Bayer subsidiary
M2 - Wed Jun 05, 9:32AM CDT
The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ:CPTS). As of the expiration of the offer period last night, 31,983,536 shares were validly tendered and not withdrawn in the tender offer, representing approximately 96.4 percent of the currently outstanding shares -- including 2,198,177 shares delivered through notices of guaranteed delivery, representing approximately 6.6 percent of the currently outstanding shares. Bayer has accepted for payment all shares validly tendered into and not withdrawn from the tender offer and will promptly make payment for such shares.
Bayer completes offer for Conceptus shares
By The Associated Press - AP - Wed Jun 05, 5:58AM CDT
German drug company Bayer AG has acquired a majority stake in birth control maker Conceptus Inc. and expects its $1.1 billion purchase of the California company to be completed soon.
Tender offer successful: Bayer acquires majority interest in Conceptus
PR Newswire - Wed Jun 05, 1:30AM CDT
The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ: CPTS). As of the expiration of the offer period last night, 31,983,536 shares were validly tendered and not withdrawn in the tender offer, representing approximately 96.4 percent of the currently outstanding shares - including 2,198,177 shares delivered through notices of guaranteed delivery, representing approximately 6.6 percent of the currently outstanding shares. Bayer has accepted for payment all shares validly tendered into and not withdrawn from the tender offer and will promptly make payment for such shares.
COV Begins Nellcor Labeling Process - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 31, 10:45PM CDT
Covidien has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for CCHD screening in infants.
Medtronic Endovascular Biz in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 31, 6:20PM CDT
Medtronic gain FDA approval for two products under its endovascular aortic repair portfolio.
The Zacks Analyst Blog Highlights: Roche Holding, Bayer, Conceptus, Teva Pharmaceutical Industries and Jazz Pharmaceuticals Public
PR Newswire - Fri May 31, 9:01AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Roche Holding AG (OTC:RHHBY), Bayer (OTC:BAYRY), Conceptus Inc. (Nasdaq:CPTS), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Jazz Pharmaceuticals Public Ltd (Nasdaq:JAZZ).
Bayer a Step Closer to Conceptus Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 30, 8:40PM CDT
Bayer received antitrust clearance from the FTC with respect to the acquisition of Conceptus.
COV Progresses Further with Spin-Off - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 30, 1:40PM CDT
Covidien's board of directors has given a green signal for the divestment, to be effective by end-June with the declaration of a dividend.
Good News for HOLX after Weak 2Q13 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 29, 6:40PM CDT
Hologic wins FDA approval for its C-View 2D imaging software.
